2018 Ischemia-Reperfusion Injury Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Ischemia-Reperfusion Injury Market

  • ID: 4577811
  • Report
  • 70 pages
  • VPA Research
10 % OFF
until Nov 30th 2018
1 of 4

FEATURED COMPANIES

  • Angion Biomedica Corp
  • Bolder Biotechnology Inc
  • CFM Pharma Holding BV
  • Glucox Biotech AB
  • MallInckrodt Plc
  • Opsona Therapeutics Ltd
  • MORE
Cardiac ischemia-reperfusion injury (IRI) is a heart related condition in which blood supply is restored to the tissue after some period of ischemia or absence of oxygen supply. The new supply causes additional complications such as inflammation, innate immunity, and oxidative stress instead of restoring regular function.

To assist researchers, investors and business development managers, the publisher has come up with a comprehensive report on Ischemia-Reperfusion Injury pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Ischemia-Reperfusion Injury pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Ischemia-Reperfusion Injury pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Angion Biomedica Corp
  • Bolder Biotechnology Inc
  • CFM Pharma Holding BV
  • Glucox Biotech AB
  • MallInckrodt Plc
  • Opsona Therapeutics Ltd
  • MORE
1 Table of Contents
1.1 List of Figures
1.2 List of Tables

2 Ischemia-Reperfusion Injury Pipeline Analysis
2.1 Disease and Pipeline Overview
2.2 Ischemia-Reperfusion Injury Pipeline Snapshot
2.3 Ischemia-Reperfusion Injury Pipeline by Phase
2.4 Ischemia-Reperfusion Injury Pipeline by Company
2.5 Ischemia-Reperfusion Injury Pipeline by Mechanism of Action

3 Ischemia-Reperfusion Injury- Company Wise Pipeline Analysis
Angion Biomedica Corp
Armaron Bio Pty Ltd
BioMedCore Inc
Bolder Biotechnology Inc
Catalyst Biosciences Inc
Celdara Medical LLC
CFM Pharma Holding BV
Corline Biomedical AB
Faraday Pharmaceuticals
Glucox Biotech AB
Ischemix Inc
MallInckrodt Plc
Miragen Therapeutics Inc
NovelMed Therapeutics Inc
Opsona Therapeutics Ltd
Pharming Group NV
Prolong Pharmaceuticals LLC
Prothix BV
Radikal Therapeutics Inc
SBI Pharmaceuticals Co Ltd
TheraSource LLC
TRIM-edicine Inc
X-In8 Biologicals Corp
List Continues..


4 Ischemia-Reperfusion Injury R&D Pipeline Snapshots
Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/ License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details

5 Recent Developments in Ischemia-Reperfusion Injury Pipeline

6 Appendix
6.1 About the Publisher
6.2 Sources and Research Methodology

Figures
Figure 1: Ischemia-Reperfusion Injury Pipeline by Phase, H2- 2018
Figure 2: Ischemia-Reperfusion Injury Pipeline by Companies, H2- 2018
Figure 3: Company Wise Pipeline Drug Phases, H2- 2018
Figure 4: Ischemia-Reperfusion Injury Pipeline by Mechanism of Action, H2- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H2- 2018

Tables
Ischemia-Reperfusion Injury Pipeline by Phase, H2- 2018
Ischemia-Reperfusion Injury Pipeline by Companies, H2- 2018
Ischemia-Reperfusion Injury Pipeline by Mechanism of Action, H2- 2018
Table 1: Angion Biomedica Corp Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 2: Armaron Bio Pty Ltd Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 3: BioMedCore Inc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 4: Bolder Biotechnology Inc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 5: Catalyst Biosciences Inc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 6: Celdara Medical LLC Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 7: CFM Pharma Holding BV Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 8: Corline Biomedical AB Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 9: Faraday Pharmaceuticals Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 10: Glucox Biotech AB Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 11: Ischemix Inc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 12: MallInckrodt Plc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 13: Miragen Therapeutics Inc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 14: NovelMed Therapeutics Inc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 15: Opsona Therapeutics Ltd Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 16: Pharming Group NV Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 17: Prolong Pharmaceuticals LLC Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 18: Prothix BV Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 19: Radikal Therapeutics Inc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 20: SBI Pharmaceuticals Co Ltd Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 21: TheraSource LLC Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 22: TRIM-edicine Inc Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 23: X-In8 Biologicals Corp Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Table 24: List Continues.. Ischemia-Reperfusion Injury Pipeline Drugs, H2- 2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Angion Biomedica Corp
  • Armaron Bio Pty Ltd
  • BioMedCore Inc
  • Bolder Biotechnology Inc
  • Catalyst Biosciences Inc
  • Celdara Medical LLC
  • CFM Pharma Holding BV
  • Corline Biomedical AB
  • Faraday Pharmaceuticals
  • Glucox Biotech AB
  • Ischemix Inc
  • MallInckrodt Plc
  • Miragen Therapeutics Inc
  • NovelMed Therapeutics Inc
  • Opsona Therapeutics Ltd
  • Pharming Group NV
  • Prolong Pharmaceuticals LLC
  • Prothix BV
  • Radikal Therapeutics Inc
  • SBI Pharmaceuticals Co Ltd
  • TheraSource LLC
  • TRIM-edicine Inc
  • X-In8 Biologicals Corp
  • List Continues….
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll